GenePool From Station X To Help Epic Sciences Analyze Circulating Tumor Cell Data

SAN FRANCISCO--(BUSINESS WIRE)--Station X, Inc., a pioneer in solving big data analytics and platform integration challenges for customers engaging in genomics-based clinical research and medical applications, today announced that Epic Sciences will use its GenePool® platform to facilitate data interpretation and collaboration with biopharmaceutical companies developing companion diagnostics based on the company’s innovative circulating tumor cell (CTC) technology.

Back to news